Annual report 2022 - record sales with full focus on growing the core business

30 Mar 2023 08:00 CEST

STOCKHOLM - March 30th, 2023- ContextVision, a medical technology software
company specializing in image processing and image analysis, today presents
their Annual Report for 2022.

The Annual Report gives additional information about the record year, where net
sales increased by 20% compared to 2021, and EBITDA ended at 49 MSEK or 42%.
2022 was also a unique year in the company's history, due to the spin-off of
Inify Laboratories AB to the shareholders. Since February 2022, previously split
costs are fully allocated to the remaining core business within medical imaging.
With solid financials in the core business and a growth plan in place to
maintain growth above market, the board of directors is proposing a dividend of
0.30 SEK/share for the financial year 2022.

Printed copies of the report will be distributed upon request by email:
finance@contextvision.se

For further information, please contact:

Markus Hökerberg (CFO)

tel +46 (0)8 7503550, e-mail markush@contextvision.se

About ContextVision
ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound, X
-ray and MRI equipment around the world.

Our expertise is to develop powerful software products, based on proprietary
technology and artificial intelligence for image-based applications. Our cutting
-edge technology helps clinicians accurately interpret medical images, a crucial
foundation for better diagnosis and treatment.

The company, established in 1983, is based in Sweden with local representation
in the US, Japan, China and Korea. ContextVision is listed on the Oslo Stock
Exchange under the ticker CONTX.

####

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site

586618_549300DGJB24U1VKHC98_2022_12_31_sv.zip
586618_Remuneration_report_2022.pdf
586618_ContextVision_Annual_Report_2022.pdf